Sun Pharma Advanced Research to launch Dry Powder Inhaler

15 Jun 2011 Evaluate

Sun Pharma Advanced Research Company (SPARC) is all set to launch its dry powder inhaler in the country in the next two months. The company has developed a Dry Powder Inhaler (DPI) compliant to US Food and Drug Administration (USFDA) and European requirements.

The pre-metered, 60 dose, inhalation activated device for the administration of combination of inhaled steroids and bronchodilator drugs delivers a uniform dose over a range of patient effort. However, the company has not disclosed the possible price range of the product.

The company, which recently launched its Timolol OD eye drops in the country, is also looking to market the products in emerging markets, including China.

SPARC is engaged in the pharmaceutical research and development. The company’s core focus is innovation and new product development for global markets. SPARC undertakes projects in research and technology for new chemical entities (NCE’s) or new molecules, and novel drug delivery systems (NDDS).

Sun Pharma Adv. Res Share Price

190.40 -5.70 (-2.91%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 847.55
Sagility India 28.27
AGS Transact Tech 79.58
Just Dial 1050.60
Krystal Integrated 638.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.